Buy Stocks Easy | About Us

September 19, 2020

CTMX

Buy CytomX Therapeutics, Inc. Stock (symbol: CTMX) Easy Online

Company Name: CytomX Therapeutics, Inc.

Symbol: CTMX

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2015

CTMX Current Share Price

Today's CTMX ( CytomX Therapeutics, Inc. ) opening price: $8.7400

Yesterday's CTMX ( CytomX Therapeutics, Inc. ) closing price: $8.6750

CytomX Therapeutics, Inc. Stock ( symbol: CTMX ) Price Chart since IPO (2015):

12 Months CytomX Therapeutics, Inc. Stock ( symbol: CTMX ) Price Chart

Popular Questions about CytomX Therapeutics, Inc. Public Stock ( CTMX )

A: CytomX Therapeutics, Inc. stock symbol (also called stock or share ticker) is CTMX

A: CytomX Therapeutics, Inc. IPO (Initial Public Offering) took place on 2015

A: CytomX Therapeutics, Inc.'s stock (CTMX symbol) price at ther IPO (initial Public Offering) was $8.7400

Q: Is CTMX stock worth buying at the moment?

A: The CTMX stock performance since 2019 are rather disappointing. If you had bought 1 share of CytomX Therapeutics, Inc. stock (symbol: CTMX) at the beginning of 2019, at the opening share price of $16.9800, you would be left with exactly $8.7400 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy CytomX Therapeutics, Inc. Stock Easy Online

CytomX Therapeutics, Inc. Stock Ticker Price Chart since IPO:

CytomX Therapeutics, Inc. Stock Price Yesterday

CytomX Therapeutics, Inc. Stock Price – Last Week

CytomX Therapeutics, Inc. Stock Price – Last Month

CytomX Therapeutics, Inc. Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

http://www.globenewswire.com/news-release/2019/12/19/1962791/0/en/CytomX-Therapeutics-Provides-Updates-on-Lead-Clinical-Programs-and-2020-Portfolio-Outlook.html

CytomX Therapeutics Provides Updates on Lead Clinical Programs and 2020 Portfolio Outlook

- Wholly-Owned anti-PD-L1 and anti-CD166 Programs Entering Phase ...

http://www.globenewswire.com/news-release/2019/12/17/1961878/0/en/CytomX-Therapeutics-Announces-New-Employment-Inducement-Grants.html

CytomX Therapeutics Announces New Employment Inducement Grants

SOUTH SAN FRANCISCO, Calif., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Cy...

http://www.globenewswire.com/news-release/2019/12/06/1957456/0/en/CytomX-Therapeutics-Announces-New-Employment-Inducement-Grants.html

CytomX Therapeutics Announces New Employment Inducement Grants.

SOUTH SAN FRANCISCO, Calif., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Cy...

https://www.benzinga.com/analyst-ratings/analyst-color/19/11/14777556/wedbush-downgrades-cytomx-due-to-lack-of-clarity-on-development-paths

Wedbush Downgrades CytomX Due To Lack Of Clarity On Development Paths

CytomX Therapeutics Inc (NASDAQ: CTMX) reported disappointing third...

https://seekingalpha.com/article/4304096-cytomx-therapeutics-inc-ctmx-ceo-sean-mccarthy-q3-2019-results-earnings-call-transcript

CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2019 Results - Earnings Call Transcript

CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2019 Resul...

http://www.globenewswire.com/news-release/2019/10/24/1934911/0/en/CytomX-Therapeutics-to-Announce-Third-Quarter-2019-Financial-Results.html

CytomX Therapeutics to Announce Third Quarter 2019 Financial Results

Teleconference Scheduled for November 7, 2019, at 5:00 p.m. ET Tele...

http://www.globenewswire.com/news-release/2019/10/14/1929138/0/en/CytomX-Therapeutics-Announces-Appointment-of-Amy-C-Peterson-M-D-as-Chief-Development-Officer.html

CytomX Therapeutics Announces Appointment of Amy C. Peterson, M.D.

-Industry Veteran Joins to Advance Maturing Platform and Pipeline t...

http://www.globenewswire.com/news-release/2019/08/28/1907692/0/en/CytomX-Therapeutics-to-Present-at-Upcoming-Healthcare-Conferences.html

CytomX Therapeutics to Present at Upcoming Healthcare Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Cy...

https://seekingalpha.com/article/4283043-cytomx-therapeutics-inc-ctmx-ceo-sean-mccarthy-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts

CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q2 2019 Results - Earnings Call Transcript

CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q2 2019 Resul...

All right reserved Buy Stocks Easy , 2019.